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Germany.Mono-glucosylation of (H/K/N)Ras by Clostridium sordellii lethal toxin (TcsL) blocks critical survival
signaling pathways, resulting in apoptotic cell death. One yet unsolved problem in studies on TcsL is
the lack of a method allowing the speciﬁc detection of (H/K/N)Ras glucosylation. In this study, we
identify the Ras(Mab 27H5) antibody as a glucosylation-sensitive antibody capable for the immuno-
blot detection of (H/K/N)Ras glucosylation in TcsL-treated cells. Alternative Ras antibodies including
the K-Ras(Mab F234) antibody or the v-H-Ras(Mab Y13-159) antibody recognize Ras proteins regard-
less of glucosylation. (H/K)Ras are further shown to be more efﬁcaciously glucosylated by TcsL than
Rac1 in rat basophilic leukemia cells as well as in a cell-free system.
Structured summary:
MINT-7261742: TcsL (uniprotkb:Q46342) enzymaticly reacts (MI:0414) H-RAS (uniprotkb:P01112) by
enzymatic studies (MI:0415)
MINT-7261729: TcsL (uniprotkb:Q46342) enzymaticly reacts (MI:0414) Rac1 (uniprotkb:P63000) by enzy-
matic studies (MI:0415)
MINT-7261772: TcsL (uniprotkb:Q46342) enzymaticly reacts (MI:0414) K-RAS (uniprotkb:P01116) by
enzymatic studies (MI:0415)
MINT-7261784: TcsL (uniprotkb:Q46342) enzymaticly reacts (MI:0414) N-RAS (uniprotkb:P01111) by
enzymatic studies (MI:0415)
 2009 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Lethal toxin (TcsL) and hemorrhagic toxin (TcsH) are regarded
as the major virulence factors ofClostridium sordellii-associated dis-
eases, including enteritis and enterotoxaemia in cattle and sheep
and myo-necrosis and gangrene in humans [1,2]. TcsL and TcsH ex-
ert their biological activity through mono-glucosylation of Rho and
Ras proteins at a pivotal threonine within the effector loop (Thr-37
in RhoA, Thr-35 in Rac/Cdc42 or (H/K/N)Ras) [3,4]. Mono-glucosy-
lation uncouples Rho/Ras proteins from their regulatory proteins
and effector proteins and renders them functional inactive [5–8].
While TcsH speciﬁcally glucosylates Rho proteins, TcsL glucosy-
lates Rac as well as the Ras family proteins (H/K/N/R)Ras, Rap(1/
2), and Ral [9–12]. Treatment of cultured cells with TcsL results
in actin re-organization (‘‘cytopathic effect”), that is likely basedchemical Societies. Published by E
. Genth).
sität Mainz, D-55131 Mainz,on Rac1 glucosylation [13]. TcsL further causes apoptotic cell death
(‘‘cytotoxic effect”), likely based on the inhibition of (H/K/N)Ras/
phosphatidylinositide 30-OH kinase (PI3 K)/Akt survival signaling
[10,14,15].
We recently identiﬁed the Rac1(Mab 102) antibody as a
glucosylation-sensitive antibody allowing the immunoblot detec-
tion of Rac1 glucosylation [10,16,17]. This non-radioactive method
has been appreciated by many researchers in the ﬁeld [18,19]. One
yet unsolved problem in studies on TcsL is the lack of a method
allowing the detection of (H/K/N)Ras glucosylation. The glucosyla-
tion of cellular Rho proteins can be tracked by either sequential
[32P]ADP-ribosylation or sequential [14C]glucosylation [16]. The
levels of endogenous (H/K/N)Ras, however, are low (compared to
that of Rho proteins) in most cell lines, for which reason [14C]glu-
cosylated, endogenous (H/K/N)Ras is only detected upon immuno-
precipitation [3]. In this study, we characterize the Ras(Mab 27H5)
antibody as a glucosylation-sensitive antibody capable for the
immunoblot detection of (H/K/N)Ras glucosylation in TcsL-treated
cells. We further show that (H/K)Ras are more efﬁcaciously glu-
cosylated than Rac1 in TcsL-treated rat basophilic leukemia cells.lsevier B.V. All rights reserved.
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Fig. 1. Detection of (H/K/N)Ras by Ras antibodies. Decreasing amounts (60 ng,
18 ng, 6 ng) of either GST-tagged H-Ras, K-Ras, or N-Ras were analyzed for
immunoblot detection using the indicated antibodies. The displayed immunoblots
are representative from three independent experiments.
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2.1. Materials
Commercially obtained reagents: UDP-[14C]glucose (Bio-
trend); antibodies: K-Ras(Mab F234, SantaCruz); Ras(Mab
27H5, Cell Signaling); v-H-Ras(Mab Y13-259, Calbiochem);
Rac1(Mab 102; Transduction Lab); Rac1(Mab 23A8, Upstate);
RhoA(Mab 26C4, SantaCruz); RhoB (Mab C-5, SantaCruz); GST
(Pab Z-5; SantaCruz), b-actin (Mab AC-40, Sigma), and horserad-
ish peroxidase conjugated secondary antibodies rabbit/mouse
(Rockland).
2.2. Methods
2.2.1. Toxin puriﬁcation
TcdBF was puriﬁed from C. difﬁcile serotype F strain 1470 and
TcsL from C. sordellii strain 6018 as described [20]. Brieﬂy, the tox-
ins were precipitated from culture supernatants of the respective
strain by 70% ammonium sulfate saturation. Subsequently, the tox-
ins were dialyzed and loaded onto MonoQ columns. After dialysis
against buffer (50 mM TRIS, pH 7.4, 15 mM NaCl), the toxins were
ready for use.
2.2.2. Protein puriﬁcation
GST-tagged Rho and Ras proteins were expressed in Escherichia
coli using the pGEX-2T vector system and afﬁnity puriﬁed using
Glutathion-Sepharose Beads (AP Biotech).
2.2.3. Cell culture
Rat basophilic leukemia (RBL-2H3) cells that express (H/K)Ras
but not N-Ras were grown as adherent monolayers on tissue cul-
ture ﬂasks in minimum essential medium plus Earle’s salts (MEM
plus Earle’s; Biochrom) supplemented with 15% heat-inactivated
fetal calf serum, 100 lg/mL penicillin, 100 U/mL streptomycin,
and 1 mM sodium pyruvate. Cells were maintained in 5% CO2 at
37 C. Upon conﬂuence, cells were passaged. For all experiments,
subconﬂuent cells in 3 cm dishes were treated with TcdBF or TcsL
as indicated for 4 h.
2.2.4. Sequential [14C]glucosylation
Cells were washed and lysed in a buffer containing NaCl
(150 mM), Tris (50 mM, pH 7.2), MgCl2 (5 mM), PMSF (1 mM),
and NP40 (1%). After sonication, the soluble fraction was prepared
by centrifugation and incubated with TcdBF or TcsL, respectively,
in the presence of UDP-[14C]glucose for 300 at 37 C. The reaction
was terminated by addition of Laemmli sample buffer. Subse-
quently, the samples were separated by SDS PAGE and subjected
to PhosphoImager analysis.
2.2.5. Western blot analysis
Complete lysate proteins were separated using SDS–PAGE and
subsequently transferred onto nitrocellulose membranes. Mem-
branes were blocked with 5% (w/v) non-fat dried milk in 50 mM
Tris, pH 7.2, 150 mM NaCl, 0.05% TWEEN 20 for 60 min; incubation
with primary antibody was conducted over night at 4 C. After
treatment of the membrane with secondary antibody (1 h), pro-
teins were detected with ECL Femto (Pierce). For immunoblot
detection of Ras and Rac1 from cell lysates the following antibody
concentrations were applied: Ras(Mab 27H5) 0.5 lg/ml, K-Ras(-
Mab F234) 0.5 lg/ml, Rac1(Mab 102) 0.25 lg/ml, Rac1(Mab
23A8) 0.3 lg/ml. For the immunoblot detection of GST-tagged
Ras proteins the following antibody concentrations were applied:
Ras(Mab 27H5) 5 ng/ml, K-Ras(Mab F234) 20 ng/ml, v-H-Ras(Mab
Y13-259) 50 ng/ml, GST(Pab Z-5) 5 ng/ml.2.2.6. Glucosylation reaction
Recombinant (H/K/N)Ras and Rac1 (2 lg) were incubated with
or without TcsL in glucosylation buffer (50 mM Tris, pH 7.2,
150 mM NaCl, 100 mM KCl, 1 mM MnCl2, 5 mM MgCl2, 100 lg/
ml BSA, 10 lM UDP-[14C]glucose, 10 lM UDP-glucose) at 37 C
for 30 min or the indicated periods. The reaction was terminated
by addition of Laemmli sample buffer. Proteins were separated
by SDS–PAGE and analyzed by immunoblotting and phosphorIm-
aging (Cyclone, Packard).
2.2.7. Statistical analysis
The experimental data were all determined to be statistically
accurate to a standard deviation of not greater than 10%. The ki-
netic parameters were determined from Eadie–Hofstee plots of ini-
tial rates of reaction as a function of substrate protein
concentration.
3. Results
3.1. Effect of glucosylation at Thr-35 on the recognition of Ras isoforms
by Ras antibodies
Several anti-Ras antibodies were screened for their reactivity
with GST-tagged versions of H-Ras, K-Ras, and N-Ras using immu-
noblot analysis (Fig. 1). The Ras(Mab27H5), the v-H-Ras(Y13-259),
and the GST(Z-5) antibodies equally detected either GST-tagged H-
Ras, K-Ras, or N-Ras (Fig. 1). In contrast, the K-Ras(Mab F234) anti-
body speciﬁcally recognized K-Ras but recognized neither H-Ras
nor N-Ras (Fig. 1).
The antibodies were next screened for their ability to detect
glucosylated (H/K/N)Ras. Therefore, GST-tagged versions of either
K-Ras, H-Ras, or N-Ras were [14C]glucosylated with TcsL or left
non-glucosylated. [14C]glucosylation of either K-Ras (Fig. 2A), H-
Ras (Fig. 2B), or N-Ras (Fig. 2C) was detected by autoradiography.
GST-K-Ras was detected by either the GST(Pab Z-5) antibody, the
v-H-Ras(Mab Y13-259) antibody, or the K-Ras(Mab F234) antibody
regardless of glucosylation (Fig. 2A). In contrast, detection of glu-
cosylated K-Ras (Fig. 2A), glucosylated H-Ras (Fig. 2B), and glu-
cosylated N-Ras (Fig. 2C) by the Ras(Mab 27H5) antibody was
strongly reduced. The GST(Z-5) antibody or the v-H-Ras(Mab
Y13-259) antibody detected H-Ras (Fig. 2B) or N-Ras (Fig. 2C)
regardless of glucosylation. Signal intensities of immunoblot detec-
tion of either K-Ras, H-Ras, or N-Ras by either the glucosylation-
sensitive Ras(Mab 27H5) or a selected antibody, that detected
either Ras protein regardless of glucosylation, was densitometric-
ally quantiﬁed (Fig. 2D). Detection of either H-Ras, K-Ras, or
N-Ras by the Ras(Mab 27H5) antibody (not by the other applied
antibodies) was thus sensitive to TcsL-catalysed glucosylation at
Thr-35.
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Fig. 2. Distinct immunoblot recognition of glucosylated and non-glucosylated Ras isoforms. (A–C) GST-tagged Ras isoforms (K-Ras, A; H-Ras, B; N-Ras, C) were
[14C]glucosylated with TcsL or left non-glucosylated. Decreasing amounts (2 lg, 0.6 lg, 0.2 lg) of [14C]glucosylated Ras were analyzed by autoradiography. Decreasing
amounts (60 ng, 18 ng, 6 ng) of glucosylated or non-glucosylated Ras were analyzed by immunoblot using the indicated antibodies. The Ras(Mab 27H5) antibody failed to
detect glucosylated (H/K/N)Ras, while all other antibodies recognized (H/K/N)Ras regardless of glucosylation. The displayed immunoblots are representative from three
independent experiments. (D) Difference in the recognition of glucosylated (H/K/N)Ras (gray lines and symbols) and non-glucosylated (H/K/N)Ras (black lines and symbols).
Signal intensities from immunoblots using either the glucosylation-sensitive Ras(Mab 27H5) antibody (upper panel) or a selected antibody that detected either Ras protein
regardless of glucosylation (lower panel) were densitometrically analyzed and plotted against the amount of either Ras protein as indicated.
S.C. Huelsenbeck et al. / FEBS Letters 583 (2009) 3133–3139 31353.2. Recognition of Rho/Ras proteins from TcsL-treated RBL cells
To test if anti-Ras(Mab 27H5) was capable of recognizing the
glucosylation of cellular Ras proteins, rat basophilic leukemia(RBL) cells were treated with increasing concentrations of TcsL
for 4 h. RBL cells express non-oncogenic H-Ras and K-Ras but
not N-Ras [21]. The immunoblot detection of (H/K)Ras by the
Ras(Mab 27H5) antibody decreased in response to increasing
3136 S.C. Huelsenbeck et al. / FEBS Letters 583 (2009) 3133–3139concentrations of TcsL (Fig. 3A). In contrast, detection of K-Ras
using the K-Ras(Mab F234) antibody showed no decrease in Ras
detection, indicating that the cellular level of K-Ras was not chan-
ged upon TcsL treatment. These observations conﬁrmed that
decreasing detection of (H/K)Ras by the Ras(Mab 27H5) antibody
was due to glucosylation but not due to degradation.
The Rho family protein Rac1 is a further substrate of TcsL [10].
Rac1 glucosylation in TcsL-treated RBL cells was analyzed using the
glucosylation-sensitive Rac1(Mab 102) antibody [16]. Immunoblot
detection of Rac1 decreased in response to increasing concentra-
tions of TcsL (Fig. 3A). The cellular level of Rac1 was not changed
upon TcsL treatment (as analyzed using the Rac1(Mab 23A8) anti-
body, conﬁrming that decreasing Rac1 detection by the Rac1(Mab
102) antibody was due to glucosylation but not due to degradation.
Interestingly, (H/K)Ras glucosylation and Rac1 glucosylation dif-
fered in their kinectis, as (H/K)Ras was more efﬁcaciously glucosy-
lated than Rac1 (Fig. 3A).
Sequential glucosylation is an established biochemical method
to assess the amount of intracellularly glucosylated low molecu-
lar weight GTP-binding proteins [12,22]. Lysates from TcsL-trea-
ted cells were subjected to sequential in vitro [14C]glucosylationTcsL Tc
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Fig. 3. Distinct kinetics of TcsL-catalysed Ras and Rac1 glucosylation in rat basophilic leuk
basophilic leukemia (RBL) cells. RBL cells were exposed to the indicated concentration
[14C]glucosylation or immunoblot analysis using the indicated antibodies. Immunoblots
kinetics of Ras and Rac1 glucosylation. Signal intensities obtained from immunoblots blo
from TcsL-treated (black lines and symbols) or TcdBF-treated (gray lines and symbols) R
K)Ras or Rac1 from non-treated cells was set 1.0.applying TcsL. The level of glucosylated (i.e. non-modiﬁed in the
lysates) cellular small GTPases decreased in response to increas-
ing TcsL concentrations, reﬂecting their glucosylation (Fig. 3A).
Sequential [14C]glucosylation of small GTPases and Rac1 glucosy-
lation (analyzed by the Rac1(Mab 102) antibody) displayed com-
parable kinetics of substrate glucosylation, showing that
sequential glucosylation and immunoblot detection of Rac1 glu-
cosylation were equivalent methods to assess cellular activity of
TcsL.
The signals obtained applying the glucosylation-sensitive
Rac1(102) or Ras(27H5) antibodies were densitometrically ana-
lyzed and normalized to b-actin (Fig. 3B). In TcsL-treated cells,
(H/K)Ras was one to two orders of magnitude more efﬁcaciously
glucosylated than Rac1 (Fig. 3B).
The level of RhoA (that is not glucosylated by TcsL) was not
changed upon TcsL treatment (Fig. 3A). In contrast, expression of
RhoB (that is also not glucosylated by TcsL) was strongly increased
in a TcsL concentration-dependent manner. RhoB expression inver-
sely correlated with (H/K)Ras glucosylation, reﬂecting that RhoB
expression depended on ‘‘de-suppression” of the (H/K/N)Ras-
dependent RhoB suppression [10,23,24].K-Ras (Mab F234)
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BL cells were quantiﬁed and normalized to b-actin. The concentration of either (H/
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Toxin B from the variant C. difﬁcile serotype F strain 1470
(TcdBF) shares most of its substrate proteins with TcsL, i.e. Rac1,
RhoG, TC10, R-Ras, and Rap(1,2), except for (H/K/N)Ras that is glu-
cosylated by TcsL but not by TcdBF [10]. Detection of (H/K)Ras
using the glucosylation-sensitive Ras(Mab 27H5) antibody did
not decrease, showing that (H/K)Ras were (expectedly) not glu-
cosylated in TcdBF-treated RBL cells (Fig. 3A). In contrast, TcdBF
concentration-dependently induced glucosylation of Rho proteins,
as analyzed in terms of sequential [14C]glucosylation and Rac1 glu-
cosylation applying the glucosylation-sensitive anti-Rac1(Mab
102) antibody (Fig. 3A). The cellular levels of K-Ras, Rac1, RhoA,
or b-actin did not change upon TcdBF treatment (Fig. 3A). In line
with a former report [23], a faint RhoB expression was observed
at a high TcdBF concentration (Fig. 3A). The observation that (H/
K)Ras glucosylation was detected in TcsL – but not in TcdBF-trea-
ted cells conﬁrmed that immunoblot analysis using the Ras(Mab
27H5) antibody speciﬁcally tracked (H/K)Ras glucosylation
(Fig. 3A and B).
Rac1 was more efﬁcaciously glucosylated in TcsL-treated than
in TcdBF-treated RBL cells (Fig. 3A and B), corroborating recent
data [10]. Fibroblasts, however, exhibit an inverse sensitivity of
Rac1 glucosylation, as Rac1 is more efﬁcaciously glucosylated in
TcdBF-treated ﬁbroblasts compared to TcsL-treated ﬁbroblasts
[22,23]. As TcsL and TcdBF exhibit comparable kinetics of Rac1 glu-
cosylation in a cell-free system (unpublished observation), this dif-
ference in the sensitivity to cellular Rac1 glucosylation is likely
based on distinct kinetics of TcsL and TcdBF internalisation into
either RBL cells or ﬁbroblasts.
3.4. Distinct kinetics of TcsL-catalysed (H/K)Ras and Rac1
glucosylation
One important ﬁnding of this study was that (H/K)Ras were
more efﬁcaciously glucosylated than Rac1 in TcsL-treated RBL cells
(Fig. 3A and B). There are three possible explanations for this differ-
ence: (i) (H/K)Ras and Rac1 exhibit distinct cellular susceptibility
for glucosylation; (ii) the binding of the Ras(27H5) antibody is
more effectively reduced by the glucosylation than binding of the
Rac1(102) antibody; and (iii) (H/K)Ras are preferred substrates of
TcsL compared to Rac1, i.e. the distinct kinetics of (H/K)Ras and
Rac1 glucosylation are due to an intrinsic property of the substrate
proteins. To corroborate the latter hypothesis, TcsL-catalysed
[14C]glucosylation of Ras and Rac1 was analyzed in a cell-free as-
say. K-Ras was more effectively glucosylated than Rac1, as the
kinetics of K-Ras glucosylation exhibited a higher initial rate of
the glucosyltransferase reaction and a higher Vmax value (Fig. 4A
and B). The initial rates observed for H-Ras and N-Ras were compa-
rable to that observed for K-Ras (Fig. 4B). The increase in K-Ras glu-
cosylation (as tracked by autoradiography) was reﬂected by a
decrease in the immunoblot detection of K-Ras using the
Ras(27H5) antibody (Fig. 4A). In contrast, the K-Ras(F234) antibody
detected K-Ras to a comparable extent regardless of increasing
[14C]glucosylation (Fig. 4A). These observations conﬁrmed that
the Ras(27H5) antibody was a glucosylation-sensitive antibody.
Initial rates of the glucosyltransferase reaction were further
analyzed in a protein substrate concentration-dependent manner
(Fig. 4C). The K-Ras concentration required for effective glucosyla-
tion was about one order of magnitude lower than that required
for effective Rac1 glucosylation by TcsL (Fig. 4C). The Km value
for K-Ras was estimated as 18 ± 3 lM from Eadie-Hofstee lineari-
zation. Thus, (H/K/N)Ras were preferred substrates of TcsL-cata-
lysed glucosylation (compared to Rac1), suggesting that theobserved difference in TcsL-catalysed (H/K)Ras and Rac1 glucosyla-
tion in RBL cells was an intrinsic property of the substrate proteins.
4. Discussion
The three mammalian ras genes (H-ras, K-ras, and N-ras) encode
three highly related GTP-binding proteins of 189 amino acids in
length. The N-terminal region (covering amino acids 1–86) harbors
amino acids critical for GTP-binding and GTP-hydrolysis as well as
the Ras effector binding domain (amino acids 32–40), which is the
critical interaction site with all known downstream targets of Ras
[25]. Thr-35 located within the effector binding domain is the
acceptor amino acids for TcsL-catalysed mono-glucosylation. The
N-terminal region exhibits an identity of 100% at the level of amino
acids among H-Ras, K-Ras, and N-Ras. The three Ras isoforms exhi-
bit a similarity at amino acid level of 85% within the intermediate
region (covering amino acids 87–167). In contrast, the three Ras
isoforms do not show any sequence similarities in the C-terminal
hypervariable region (amino acids 165–189), except for a con-
served CAAX motif (C, cysteine; A, aliphatic amino acid; X, methi-
onine or serine) at the very C-terminal end. The CAAX motif, that is
present in all Ras family proteins, directs posttranslational process-
ing including isoprenylation [25].
The Ras(Mab 27H5) antibody has been generated using the N-
terminal region of K-Ras as antigen (according to the manufac-
turer’s instructions). Due to an identity of 100% within this domain,
H-Ras, K-Ras, and N-Ras are comparably detected by the Ras(Mab
27H5) antibody. The N-terminal region of (H/K/N)Ras harbors
Thr-35, the acceptor amino acid of TcsL-catalysed glucosylation.
Mono-glucosylation at Thr-35 almost completely reduces detec-
tion of either H-Ras, K-Ras, or N-Ras by the Ras(Mab 27H5) anti-
body, leading to the conclusion that glucosylation interferes with
binding of the antibody to either Ras isoform. The Ras(Mab
27H5) antibody does not precipitate (H/K/N)Ras, for which reason
direct analysis of the effect of glucosylation on the Ras – Ras(Mab
27H5) antibody interaction is not available (data not shown). Our
observations lead to the classiﬁcation of the Ras(Mab 27H5) anti-
body as a glucosylation-sensitive antibody, allowing the detection
of Ras glucoslyation in cell-free as well as in cellular systems. This
capability makes the Ras(Mab 27H5) antibody a valuable tool for
the recognition of TcsL-catalysed glucosylation of (H/K/N)Ras.
TcsL-induced apoptosis has been suggested to be based on inhi-
bition of Ras-dependent survival signaling pathways, in particular
on the inhibition of PI3K/Akt signaling [10,14,15,26]. Evidence sug-
gesting a critical role of (H/K/N)Ras glucosylation in TcsL-induced
apoptosis is based on correlation of the biological effects and sub-
strate spectra of TcsL and isomeric TcdBF: TcsL (not TcdBF) induces
apoptosis [10]. TcsL and TcdBF share their substrates (Rac, Rap, and
R-Ras), except for (H/K/N)Ras that is speciﬁcally glucosylated by
TcsL, as analyzed in a cell-free system [10]. Correlation of apoptotic
activity and substrate spectra highlights (H/K/N)Ras glucosylation
as the critical event in TcsL-induced apoptosis. Exploiting the glu-
cosylation-sensitive Ras(Mab 27H5) antibody, we here show that
(H/K)Ras are in fact glucosylated in TcsL- but not in TcdBF-treated
RBL cells.
Comparison of the kinetics of (H/K)Ras glucosylation and Rac1
glucosylation reveals that (H/K)Ras are more efﬁcaciously glucosy-
lated than Rac1 in TcsL-treated RBL cells. This difference is also ob-
served in a cell-free assay, showing that it depends on an inherent
property of the substrate proteins rather than on (i) different bind-
ing of the glucosylation-sensitive Rac1(Mab 102) or Ras(27H5)
antibodies to glucosylated Rac1 or Ras, respectively, (ii) different
availability of the substrates proteins, or (iii) on the state of cellular
activity of the substrate proteins. The cellular state of Ras proteins
must be taken into account if studies on TcsL are performed in cells
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Fig. 4. Distinct kinetics of TcsL-catalysed (H/K/N)Ras glucosylation and Rac1 glucosylation in a cell-free system. (A) Time-dependent analysis of TcsL-catalysed
[14C]glucosylation of K-Ras and Rac1. [14C]glucosylation of GST-tagged K-Ras or Rac1 (50 lM) as indicated in the presence of TcsL (200 pM) were analyzed in a time-
dependent manner. [14C]glucosylated Rac1 or K-Ras were visualized by autoradiography and densitometrically quantiﬁed. Time-dependent glucosylation of K-Ras was
further visualized using the glucosylation-sensitive Ras(27H5) antibody. Constant amounts of K-Ras were shown using the K-Ras(F234) antibody. (B) Initial rates of TcsL-
catalysed glucosylation. GST-tagged K-Ras, H-Ras, N-Ras, or Rac1 (50 lM) were [14C]glucosylated in the presence of TcsL (200 pM) for the indicated times. [14C]glucosylated
Rac/Ras proteins were visualized by autoradiography and densitometrically quantiﬁed. (C) Protein substrate concentration-dependent [14C]glucosylation. Increasing
concentrations of either K-Ras or Rac1 (1.5, 5, 15, 50, 150 lM) were [14C]glucosylated in the presence of TcsL (200 pM) for 2 min. K-Ras was more efﬁcaciously glucosylated
than Rac1. [14C]glucosylated Rac1 and K-Ras were visualized by autoradiography. The signal intensities were densitometrically quantiﬁed.
3138 S.C. Huelsenbeck et al. / FEBS Letters 583 (2009) 3133–3139expressing oncogenic (GTP-bound) Ras including many ﬁbroblast
lines. Small GTPases in general are preferably glucosylated in their
GDP-bound state but (at least transiently) protected from glucosy-
lation in their GTP-bound state [7,13]. One must expect that Ras
transformed ﬁbroblasts exhibit a lower sensitivity to TcsL-induced
Ras glucosylation than to Rac1 glucosylation. Given that (H/K/
N)Ras glucosylation is critical for TcsL-induced apoptosis
[10,14,15,26], the missing sensitivity of oncogenic Ras to TcsL-cat-
alysed glucosylation can be deduced from the observation that
NIH3T3 ﬁbroblasts (expressing oncogenic Ras) are almost insensi-tive to TcsL-induced apoptosis (unpublished observation). In dis-
ease associated with toxigenic C. sordellii, however, TcsL targets
non-transformed cells expressing non-oncogenic Ras. RBL cells
that express non-oncogenic Ras are thus a better model to analyze
TcsL-induced effects than (transformed) cell lines expressing onco-
genic Ras.
Our observation from RBL cells that Ras is more efﬁcaciously
glucosylated than Rac1 does not meet the former studies, suggest-
ing that Rac1 glucosylation and subsequent changes of actin
dynamics (‘‘cytopathic effects”) are the key activities of TcsL [9].
S.C. Huelsenbeck et al. / FEBS Letters 583 (2009) 3133–3139 3139Further studies are required to understand the consequences of (H/
K/N)Ras glucosylation at low (sub-cytopathic) TcsL concentrations,
which may include not yet investigated effects on cell cycle
progression.
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